POLR3H
DNA-directed RNA polymerase III subunit RPC8
Also known as: C25, KIAA1665, RPC8, RPC8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y535
- Gene
- POLR3H
- Ensembl
- ENSG00000100413
- Chromosome
- 22
- Canonical length
- 204 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins
- Subcellular location
- Nucleoplasm,Vesicles,Centrosome
OverviewNCBI Gene
Enables DNA-directed RNA polymerase activity. Involved in transcription by RNA polymerase III. Located in centrosome and nucleoplasm. Part of RNA polymerase III complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
204 residues, UniProt reviewed canonical sequence.
>Q9Y535|POLR3H
1 MFVLVEMVDT VRIPPWQFER KLNDSIAEEL NKKLANKVVY NVGLCICLFD ITKLEDAYVF
61 PGDGASHTKV HFRCVVFHPF LDEILIGKIK GCSPEGVHVS LGFFDDILIP PESLQQPAKF
121 DEAEQVWVWE YETEEGAHDL YMDTGEEIRF RVVDESFVDT SPTGPSSADA TTSSEELPKK
181 EAPYTLVGSI SEPGLGLLSW WTSNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLR3H can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 42 nTPM
- amygdala: 41 nTPM
- basal ganglia: 39 nTPM
- hippocampal formation: 32 nTPM
- midbrain: 31 nTPM
- hypothalamus: 27 nTPM
Single-cell type
- late spermatids: 301 nCPM
- cardiomyocytes: 169 nCPM
- oocytes: 111 nCPM
- differentiating spermatogonia: 79 nCPM
- epicardial cells: 71 nCPM
- esophageal suprabasal cells: 63 nCPM
Immune cell
- non-classical monocyte: 19 nTPM
- intermediate monocyte: 18 nTPM
- memory B-cell: 17 nTPM
- myeloid DC: 14 nTPM
- naive B-cell: 14 nTPM
- plasmacytoid DC: 13 nTPM
Brain region
- midbrain: 35 nTPM
- thalamus: 34 nTPM
- medulla oblongata: 33 nTPM
- amygdala: 31 nTPM
- spinal cord: 31 nTPM
- hippocampal formation: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.14
- DepMap mean gene effect
- -1.59
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to virus
- innate immune response
- nucleobase-containing compound metabolic process
- transcription by RNA polymerase III
- transcription initiation at RNA polymerase III promoter
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA polymerase Rpb7-like , N-terminal
- Nucleic acid-binding, OB-fold
- RNA polymerase Rpb7-like, N-terminal domain superfamily
- RNA polymerase subunit Rpb7-like
- SHS2 domain found in N terminus of Rpb7p/Rpc25p/MJ0397
- DNA-directed RNA polymerase, subunit E/RPC8
- RNA polymerase III, subunit Rpc25
- RNA polymerase III subunit Rpc25
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POLR3H in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLR3H as an antibody target. Whether an autoantibody or antibody against POLR3H could matter depends on whether native POLR3H is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLR3H is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLR3H as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...